...
首页> 外文期刊>Tumour biology : >Let-7a suppresses glioma cell proliferation and invasion through TGF-beta/Smad3 signaling pathway by targeting HMGA2
【24h】

Let-7a suppresses glioma cell proliferation and invasion through TGF-beta/Smad3 signaling pathway by targeting HMGA2

机译:Let-7a通过靶向HMGA2抑制TGF-beta / Smad3信号通路抑制神经胶质瘤细胞增殖和侵袭

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

It has been shown that let-7a was associated with the tumorigenesis of glioma. Our study was designed to infer how let-7a targets high-mobility AT-hook 2 (HMGA2) and suppresses glioma cell proliferation, invasion, and migration. Glioma tissues from 60 glioma patients and 10 normal brain tissues were collected in this study. Real-time quantitative reverse transcription-PCR (qRT-PCR) and in situ hybridization were used to detect the expression levels of let-7a in tissues and cells. The HMGA2 and the proteins related to transforming growth factor-beta (TGF-beta)/Smad3 signaling pathway were measured by immunohistochemistry and western blot. Glioma U87 cells were transfected with either let-7a mimics, HMGA2 small interfering RNA (siRNA), let-7a mimics + HMGA2, HMGA2, or scramble. A cell counting kit-8 (CCK-8) assay was used to detect and compare the difference among various transfection groups. Glioma tumor xenograft models on mice were built to evaluate the effects of let-7a and HMGA2 siRNA on glioma tumors in vivo. The expression level of let-7a significantly downregulated in glioma tissues, while the HMGA2 positive expression rate notably increased compared with those in normal brain tissues (all P < 0.05). Moreover, the expression levels of let-7a and HMGA2 were correlated with glioma grades (all P < 0.05). The proliferation of U87 cells transfected with let-7a mimics or HMGA2 siRNA was significantly inhibited in comparison to the blank control group and the apoptosis rates of U87 cells transfected with let-7a mimics or HMGA2 siRNA were significantly higher than those in the blank control group (all P < 0.05). Let-7a or HMGA2 siRNA could remarkably attenuate the invasion and migration ability of glioma cells (all P < 0.05). Apart from that, over-expressed exogenous HMGA2 could reverse the inhibition of glioma cell metastasis and proliferation induced by let-7a. As suggested by immunohistochemistry and western blot, the expression levels of TGF-beta 1 and p-Smad3 significantly decreased compared with the blank or scramble group (all P < 0.05). Thus, let-7a and HMGA2 siRNA could effectively suppress the growth of tumors in glioma xenograft models. Let-7a may suppress the proliferation and invasion of glioma cells through mediating TGF-beta/Smad3 signaling pathway by targeting HMGA2.
机译:已经表明let-7a与神经胶质瘤的肿瘤发生有关。我们的研究旨在推断let-7a如何靶向高迁移率AT-hook 2(HMGA2)并抑制神经胶质瘤细胞的增殖,侵袭和迁移。本研究收集了来自60例神经胶质瘤患者和10例正常脑组织的神经胶质瘤组织。实时定量逆转录-PCR(qRT-PCR)和原位杂交用于检测let-7a在组织和细胞中的表达水平。 HMGA2和与转化生长因子-β(TGF-β)/ Smad3信号转导通路相关的蛋白质通过免疫组织化学和蛋白质印迹法进行了测量。用let-7a模拟物,HMGA2小干扰RNA(siRNA),let-7a模拟物+ HMGA2,HMGA2或加扰转染胶质瘤U87细胞。细胞计数试剂盒8(CCK-8)分析用于检测和比较不同转染组之间的差异。建立小鼠胶质瘤肿瘤异种移植模型,以评估let-7a和HMGA2 siRNA在体内对神经胶质瘤肿瘤的作用。胶质瘤组织中let-7a的表达水平显着下调,而HMGA2阳性表达率较正常脑组织明显升高(均P <0.05)。而且,let-7a和HMGA2的表达水平与神经胶质瘤的等级相关(均P <0.05)。与空白对照组相比,let-7a模拟物或HMGA2 siRNA转染的U87细胞的增殖受到明显抑制,并且let-7a模拟物或HMGA2 siRNA转染的U87细胞的凋亡率明显高于空白对照组。 (所有P <0.05)。 Let-7a或HMGA2 siRNA可以显着减弱胶质瘤细胞的侵袭和迁移能力(均P <0.05)。除此之外,过表达的外源HMGA2可以逆转let-7a诱导的对胶质瘤细胞转移和增殖的抑制作用。免疫组化和免疫印迹表明,与空白组或加扰组相比,TGF-beta 1和p-Smad3的表达水平显着降低(所有P <0.05)。因此,let-7a和HMGA2 siRNA可以有效抑制胶质瘤异种移植模型中肿瘤的生长。 Let-7a可能通过靶向HMGA2介导TGF-beta / Smad3信号通路来抑制胶质瘤细胞的增殖和侵袭。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号